Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRightmove Regulatory News (RMV)

Share Price Information for Rightmove (RMV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 537.00
Bid: 538.20
Ask: 538.60
Change: -8.60 (-1.58%)
Spread: 0.40 (0.074%)
Open: 548.00
High: 548.60
Low: 536.60
Prev. Close: 545.60
RMV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Mar 2014 16:43

RIGHTMOVE PLC - Director/PDMR Shareholding

RIGHTMOVE PLC - Director/PDMR Shareholding

PR Newswire

London, March 3

3 March 2014 RIGHTMOVE PLC DIRECTOR/PDMR SHAREHOLDING Rightmove plc (the "Company"), has received the following notifications todayfrom Nick McKittrick, Chief Executive Officer, Peter Brooks-Johnson, ChiefOperating Officer and Robyn Perriss, Finance Director: Nick McKittrick has confirmed that he has today been awarded Nil cost deferredshares over 9,224 ordinary shares of 1p each following achievement of the 2013bonus targets. The deferred shares are exercisable for 12 months from 3 March2016. Nick McKittrick has also been awarded Nil cost performance shares over30,018 ordinary shares of 1p each. The performance shares are exercisable for aperiod of 2 years from 3 March 2017 subject to performance criteria being met. Following this transaction, the beneficial shareholding of Nick McKittrick is130,350 ordinary shares representing 0.13% of the ordinary shares in issue(excluding shares held in treasury). Nick McKittrick also holds executive andSharesave options over 394,614 ordinary shares, deferred share awards over44,591 ordinary shares and 150,889 performance shares. Peter Brooks-Johnson has confirmed that he has today been awarded Nil costdeferred shares over 6,918 ordinary shares of 1p each following achievement ofthe 2013 bonus targets. The deferred shares are exercisable for 12 months from3 March 2016. Peter Brooks-Johnson has also been awarded Nil cost performanceshares over 25,140 ordinary shares of 1p each. The performance shares areexercisable for a period of 2 years from 3 March 2017 subject to performancecriteria being met. Following this transaction, the beneficial shareholding of Peter Brooks-Johnsonis 15,016 ordinary shares representing 0.01% of the ordinary shares in issue(excluding shares held in treasury). Peter Brooks-Johnson also holds executiveand Sharesave options over 269,972 ordinary shares, deferred share awards over32,721 ordinary shares and 98,982 performance shares. Robyn Perriss has confirmed that she has today been awarded Nil cost deferredshares over 4,353 ordinary shares of 1p each following achievement of the 2013bonus targets. The deferred shares are exercisable for 12 months from 3 March2016. Robyn Perriss has also been awarded Nil cost performance shares over19,887 ordinary shares of 1p each. The performance shares are exercisable for aperiod of 2 years from 3 March 2017 subject to performance criteria being met. Following this transaction, the beneficial shareholding of Robyn Perriss is nilordinary shares representing 0% of the ordinary shares in issue (excludingshares held in treasury). Robyn Perriss also holds executive and Sharesaveoptions over 910 ordinary shares, deferred shares awards over 9,193 ordinaryshares and 45,873 performance shares. All the above share awards were made following a meeting of the RemunerationCommittee on 3 March 2014. This announcement is made under the UKLA's Disclosure and Transparency Rule3.1.4R. Ends Name and contact number for queries:

Jenny Warburton 0207 087 0739

Date   Source Headline
10th Apr 20244:49 pmPRNTransaction in Own Shares
10th Apr 20244:35 pmPRNHolding(s) in Company
9th Apr 20244:58 pmPRNTransaction in Own Shares
8th Apr 20244:59 pmPRNTransaction in Own Shares
5th Apr 20244:49 pmPRNTransaction in Own Shares
4th Apr 20244:57 pmPRNTransaction in Own Shares
4th Apr 202411:28 amPRNDirector/PDMR Shareholding
3rd Apr 20245:08 pmPRNTransaction in Own Shares
2nd Apr 20245:16 pmPRNTransaction in Own Shares
2nd Apr 20249:19 amPRNTotal Voting Rights
28th Mar 20245:00 pmPRNTransaction in Own Shares
27th Mar 20245:01 pmPRNTransaction in Own Shares
26th Mar 20245:11 pmPRNTransaction in Own Shares
25th Mar 20244:50 pmPRNTransaction in Own Shares
22nd Mar 20244:53 pmPRNTransaction in Own Shares
22nd Mar 20242:29 pmPRNNotice of AGM
21st Mar 20245:01 pmPRNTransaction in Own Shares
20th Mar 20244:58 pmPRNTransaction in Own Shares
19th Mar 20244:49 pmPRNTransaction in Own Shares
18th Mar 20244:56 pmPRNTransaction in Own Shares
15th Mar 20244:58 pmPRNTransaction in Own Shares
15th Mar 20244:27 pmPRNDirector/PDMR Shareholding
14th Mar 20244:52 pmPRNTransaction in Own Shares
14th Mar 202410:29 amPRNDirector/PDMR Shareholding
13th Mar 20245:05 pmPRNTransaction in Own Shares
12th Mar 20244:59 pmPRNTransaction in Own Shares
11th Mar 20244:53 pmPRNTransaction in Own Shares
8th Mar 20244:57 pmPRNTransaction in Own Shares
7th Mar 20245:03 pmPRNTransaction in Own Shares
6th Mar 20245:05 pmPRNTransaction in Own Shares
5th Mar 20244:52 pmPRNTransaction in Own Shares
4th Mar 20245:47 pmPRNTransaction in Own Shares
1st Mar 20249:26 amPRNTotal Voting Rights
1st Mar 20247:00 amRNSAnnual Financial Report
13th Feb 202411:59 amPRNNotice of Results
1st Feb 202411:51 amPRNTotal Voting Rights
1st Feb 202410:17 amPRNAcquisition
31st Jan 202410:05 amPRNHolding(s) in Company
2nd Jan 20249:38 amPRNTotal Voting Rights
29th Dec 202311:22 amPRNHolding(s) in Company
28th Dec 202310:36 amPRNDirector/PDMR Shareholding
7th Dec 20233:35 pmPRNDirector/PDMR Shareholding
4th Dec 20235:14 pmPRNTransaction in Own Shares
1st Dec 20235:39 pmPRNTransaction in Own Shares
1st Dec 20239:39 amPRNTotal Voting Rights
30th Nov 20235:11 pmPRNTransaction in Own Shares
29th Nov 20235:17 pmPRNTransaction in Own Shares
28th Nov 20235:05 pmPRNTransaction in Own Shares
27th Nov 20237:00 amPRNTrading Statement
17th Nov 20235:17 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.